Related Experiment Video
Updated: Apr 20, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
Infant with cardiomyopathy: When to suspect inborn errors of metabolism?
Stephanie L Byers1, Can Ficicioglu1
1Stephanie L Byers, Can Ficicioglu, The Children's Hospital of Philadelphia, Section of Metabolic Disease, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, United States.
Insights
Inborn errors of metabolism are found in 5%-26% of pediatric cardiomyopathy cases. This review highlights key indicators for suspecting metabolic disorders and referring patients for specialized evaluation.
Area of Science:
- Metabolic disorders
- Cardiology
- Pediatrics
Background:
- Inborn errors of metabolism (IEM) are identified in 5%-26% of infants and children diagnosed with cardiomyopathy.
- While fatty acid oxidation disorders, lysosomal and glycogen storage disorders, and organic acidurias are established causes, emerging evidence points to mitochondrial dysfunction and congenital disorders of glycosylation.
Purpose of the Study:
- To guide primary care physicians and cardiologists in identifying patients with cardiomyopathy who may have an underlying inborn error of metabolism.
- To outline specific "red flags" prompting referral to a metabolic specialist for further diagnostic workup.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on IEM associated with cardiomyopathy.
- It focuses on clinical indicators and diagnostic referral criteria.
Main Results:
- A significant proportion of pediatric cardiomyopathies are linked to IEM.
- Recognizing specific clinical signs and symptoms is crucial for early diagnosis.
- Timely referral to metabolic specialists improves patient management.
Conclusions:
- Primary care physicians and cardiologists should maintain a high index of suspicion for IEM in children with cardiomyopathy.
- Prompt metabolic workup is essential for patients presenting with suggestive "red flags".
- Early identification and management of IEM can improve outcomes in pediatric cardiomyopathy.
Abstract:
Inborn errors of metabolism are identified in 5%-26% of infants and children with cardiomyopathy. Although fatty acid oxidation disorders, lysosomal and glycogen storage disorders and organic acidurias are well-known to be associated with cardiomyopathies, emerging reports suggest that mitochondrial dysfunction and congenital disorders of glycosylation may also account for a proportion of cardiomyopathies. This review article clarifies when primary care physicians and cardiologists should suspect inborn errors of metabolism in a patient with cardiomyopathy, and refer the patient to a metabolic specialist for a further metabolic work up, with specific discussions of "red flags" which should prompt additional evaluation.
Related Concept Videos
Inborn Errors of Metabolism
Cardiomyopathy I: Introduction and Classification
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanism of Cardiac Arrhythmias

